Zinc's Association with the CmPn/CmP Signaling Network in Breast Cancer Tumorigenesis

Biomolecules. 2022 Nov 11;12(11):1672. doi: 10.3390/biom12111672.

Abstract

It is well-known that serum and cellular concentrations of zinc are altered in breast cancer patients. Specifically, there are notable zinc hyper-aggregates in breast tumor cells when compared to normal mammary epithelial cells. However, the mechanisms responsible for zinc accumulation and the consequences of zinc dysregulation are poorly understood. In this review, we detailed cellular zinc regulation/dysregulation under the influence of varying levels of sex steroids and breast cancer tumorigenesis to try to better understand the intricate relationship between these factors based on our current understanding of the CmPn/CmP signaling network. We also made some efforts to propose a relationship between zinc signaling and the CmPn/CmP signaling network.

Keywords: CCM signaling complex (CSC); CmP signaling network; CmPn signaling network; Zinc; classic nuclear progesterone receptors (nPRs); non-classic membrane progesterone receptors (mPRs/PAQRs); progesterone (PRG).

Publication types

  • Review

MeSH terms

  • Breast Neoplasms* / pathology
  • Carcinogenesis
  • Cell Transformation, Neoplastic
  • Female
  • Humans
  • Signal Transduction
  • Zinc

Substances

  • Zinc

Grants and funding

This research received no external funding.